An arrhythmic episode after mercury exposure and successful treatment with chelation therapy: A case report

References (1)

1. Cohen JP, Ruha AM, Curry SC, Biswas K, Westenberger B, Ye W, et al. Plasma and urine dimercaptopropanesulfonate concentrations after dermal applica- tion of transdermal DMPS (TD-DMPS). J Med Toxicol 2013; 9: 9-15. [CrossRef] 2. Houston MC. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J Clin Hypertens 2011; 13: 621-7. [CrossRef] 3. Grandjean P, Murata K, Budtz-Jorgensen E, Weihe P. Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J Pediatr 2004; 144: 169-76. [CrossRef] 4. Yaginuma-Sakurai K, Murata K, Shimada M, Nakai K, Kurokawa N, Kameo S, et al. Intervention study on cardiac autonomic nervous effects of meth- ylmercury from seafood. Neurotoxicol Teratol 2010; 32: 240-5. [CrossRef] 5. Wossmann W, Kohl M, Gruning G, Bucsky P. Mercury intoxication presenting with hypertension and tachycardia. Arch Dis Child 1999; 80: 556-7. [CrossRef] 6. Salthammer T, Uhde E, Omelan A, Ludecke A, Moriske HJ. Estimating human indoor exposure to elemental mercury from broken compact fluorescent lamps (CFLs). Indoor Air 2012; 22: 289-98. [CrossRef] 7. Carman KB, Tutkun E, Yılmaz H, Dilber C, Dalkıran T, Çakır B, et al. Acute mercury poisoning among children in two provinces of Turkey. Eur J Pediatr 2013; 172: 821-7. [CrossRef]